Trp53 heterozygosity defines novel states impacting tumor plasticity and progression in Kras-initiated non-small cell lung cancer
V Mitheera, Abhishek Koladiya, Aatish Thennavan, Xiaojie Yu, Guillermina Lozano
This study shows that TP53 heterozygosity in Kras-mutant lung cancer affects tumor plasticity and progression, with distinct genomic and survival outcomes compared to complete TP53 loss.
bioRxiv · Oct 14, 2026 · PreprintCancer Biology